Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by love_minus_zeroon Jan 26, 2010 1:02pm

260 Views

Post# 16719992

RE: RE: Zero talent in communications at TH

Yes it is good to get rid of the chickens, but why stop there, lets get rid of a few donkeys hanging around the Thera building. They should have waited on a news release that included the change of review date, and not release it UNTIL they had a new date lined up.
Donkeys.
Complete and utter donkeys!
lmz

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features